Functional and Histological Study of Liver in Adult Rats Treated with Different Doses of Melatonin

Muna Hassan Yousef1*, Jawad Kadhim Arrak2, Sadiq Jaffer Ramadhan1

1Department of Physiology, Biochemistry, and Pharmacology College of Veterinary Medicine, University of Baghdad, Baghdad, Iraq; 2University of Mashreq, College of Pharmacy, Baghdad, Iraq.

Abstract | This study aimed to evaluate the effects of different doses of melatonin on liver function in adult rats. Eighteen Wistar adult albino rats (Rattus norvegicus), approximately 13–16 weeks old and weighing 230 ± 10 g, were randomly divided into three groups (n=6 per group) and treated orally for 30 days as follows: Group A1 received 10 mg/kg body weight (B.W) of melatonin; Group A2 received 20 mg/kg B.W of melatonin; and the control group (Group A) received distilled water. At the end of the treatment period, blood samples were collected via cardiac puncture, and serum was separated for biochemical analysis. Parameters assessed included oxidative stress markers (malondialdehyde (MDA), reduced glutathione (GSH)) and liver enzymes (aspartate aminotransferase (AST), alanine transaminase (ALT)). The results showed that melatonin administration led to a significant (P<0.05) reduction in final body weight and a marked (P<0.01) increase in MDA and AST levels in Group A2 compared to Groups A1 and control. Conversely, in Group A1, melatonin significantly (P<0.05) reduced MDA and AST levels while significantly increasing GSH levels compared to A2 and control. No significant differences were observed in ALT levels among the three groups. Histopathological examination of liver tissue revealed vascular and sinusoidal congestion in Group A2, which was absent in Groups A1 and control. In conclusion, melatonin at a dose of 10 mg/kg B.W demonstrated beneficial effects on liver function, antioxidant status, and body weight. However, a higher dose of 20 mg/kg B.W had a detrimental impact on liver function.

Keywords | ALT, Antioxidant status, AST, Body weight, Wistar albino rats


Received | March 17, 2025; Accepted | April 27, 2025; Published | May 15, 2025

*Correspondence | Muna Hassan Youssef, Department of Physiology, Biochemistry, and Pharmacology College of Veterinary Medicine, University of Baghdad, Baghdad, Iraq; Email: [email protected]

Citation | Youssef MH, Arrak JK, Ramadhan SJ (2025). Functional and histological study of liver in adult rats treated with different doses of melatonin. J. Anim. Health Prod. 13(2): 362-367.

DOI | https://dx.doi.org/10.17582/journal.jahp/2025/13.2.362.367

ISSN (Online) | 2308-2801

Copyright: 2025 by the authors. Licensee ResearchersLinks Ltd, England, UK.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).



sIntroduction

The liver, one of the primary metabolic organs found exclusively in vertebrates, performs numerous essential biological functions, including detoxification and the synthesis of proteins and other biochemicals necessary for growth and digestion (Kamoldinova, 2023). Among its key metabolic roles are the breakdown of red blood cells, conversion and storage of nutrients such as glucose and glycogen, hormone synthesis, and carbohydrate metabolism (Nogueira-Ferreira et al., 2024). Additionally, the liver acts as an accessory digestive organ by producing bile an alkaline fluid containing bile acids and cholesterol which aids in the emulsification and digestion of dietary fats. The liver is composed primarily of hepatocytes, highly specialized cells responsible for regulating a wide range of high-volume biochemical activities, including the synthesis and degradation of both simple and complex organic compounds, many of which are essential for maintaining vital physiological functions (Hyder et al., 2023).

The pineal gland produces melatonin (N-acetyl-5-methoxytryptamine or MEL), a hormone primarily secreted at night (Ahmad et al., 2023). Melatonin plays a significant role in regulating the biological clock, promoting proper sleep, and modulating immune function (Abdullah et al., 2022). It facilitates deep sleep by suppressing wake-promoting signals (Pandi-Perumal et al., 2008). Additionally, melatonin acts as a potent free radical scavenger, eliminating reactive species such as hydrogen peroxide, thereby enhancing antioxidant activity in tissues (Boutin et al., 2024). Its anti-inflammatory properties are attributed to its ability to neutralize free radicals and regulate inflammatory responses by increasing pro-inflammatory markers during the early stages of inflammation (Hernández-Velázquez et al., 2016). Melatonin is also believed to protect the liver from damage induced by certain drugs by reducing oxidative stress, mitochondrial and microsomal lipid peroxidation, and inflammatory cell infiltration (Colares et al., 2022). Furthermore, its antioxidant capabilities extend to protecting renal tissues from drug-induced damage (Dun et al., 2022). The current study aimed to investigate the effects of different doses of melatonin on liver function in adult rats.

Materials and Methods

Animals management and study design

The animals were housed in well-ventilated plastic cages, given the unrestricted availability of water and food throughout the study period. The ambient temperature was kept at 22±2°C with a 12-hour light/dark cycle for acclimatization and research purposes. Eighteen Wistar adult Albino Rats (Rattus norvegicus) (between the ages 13-16 weeks and weighing 230±10g) were separated equally among the following groups. Group A (Control): orally gavage with 0.5 ml D.W Once daily, Group (A1): orally gavage with melatonin once daily (10 mg/kg/b.w), Group (A2): orally gavage with melatonin (20 mg/kg/b.w) once daily for 30 days (Oleshchuk et al., 2019). At the final stage of the experiment blood and tissue samples were taken from euthanized animals and given intramuscular injections of ketamine 90 mg/kg B.W and xylazine 40 mg/kg B.W. The examination of the following parameters was conducted: oxidant and antioxidant status, including MDA and reduced GSH concentrations, measured according to the methods described by Burtis and Ashwood (1999) and Guidet and Shah (1989), respectively. Liver enzyme activities, specifically aspartate aminotransferase (AST) and alanine transaminase (ALT), were assessed using the COBAS INTEGRA e411 analyzer (Roche). Liver tissue samples were collected and preserved in 10% neutral buffered formalin for histological analysis. Paraffin blocks were prepared, and tissue sections were stained with hematoxylin and eosin (H&E) following the procedures outlined by Bancroft and Gamble (2008).

Body weight measurements

Animals’ body weights were measured at the start of the experiment and then weekly until the completion of experiment. Weight gain was also monitored.

Statistical analysis

The Statistical Analysis System (SAS, 2018) software was used to analyze the effects of various factors on the study parameters. Differences between means were evaluated using analysis of variance (ANOVA), and significant differences were determined using the least significant difference (LSD) test.

Results

Final weight and weight gain

The results showed that the final body weight was significantly decreased (P ≤ 0.05) in the A2 group compared to the control and A1 groups. In contrast, no significant differences were observed in final weight and weight gain between the control and A1 groups (Table 1).

 

Table 1: Effect of different melatonin doses on body weight of rats.

Groups

Mean ± SE of body weight (g)

Initial weight

Final weight

Weight gain

Control (A)

234.60 ±29.67

249.43 ±29.10 a

14.83 ±2.02

A1

185.06 ±10.61

203.22 ±9.28 ab

18.16 ±3.56

A2

179.31 ±11.28

190.58 ±12.65 b

11.28 ±2.94

LSD value

NS

*

NS

P-value

0.126

0.0492

0.284

 

Means with different letters in the same column varied significantly * (P≤0.05). Data are expressed as mean ± SE, N = 6 per group. A: control group rats were given D.W; A1: group got 10 mg/kg/B.W/day of melatonin; A2: group received 20 mg/kg B.W/day of melatonin for 30 days.

 

Antioxidative enzymes concentration

Table 2 shows that MDA activity significantly decreased (P ≤ 0.01) in the A1 group, while GSH levels significantly increased (P ≤ 0.01) in the same group compared to the control and A2 groups. Additionally, the A2 group showed no significant differences in MDA and GSH concentrations when compared with the control group.

Liver enzymes activity

The results illustrated in Table 3 revealed a significant decrease (P ≤ 0.05) in AST enzyme concentration in the A1 group compared with the control and A2 groups, while ALT enzyme concentrations showed no significant differences between the control and the treated groups.

 

Table 2: Effect of different doses of melatonin on malondialdehyde (MDA), and reduced glutathione (GSH) concentration in rats.

Groups

Mean ± SE

MDA (μmol/L)

GSH (μmol/L)

Control (A)

11.43 ±0.53 a

24.15 ±0.41 b

A1

7.92 ±0.34 b

31.83 ±0.45 a

A2

11.84 ±0.44 a

23.63 ±0.50 b

LSD value

1.367 **

1.415 **

P-value

0.0001

0.0001

 

Means with different letters in the same column varied significantly. ** (P≤0.01). Data are expressed as mean ± SE, N = 6 per group. A: control group rats were given D.W; A1: group got 10 mg/kg/B.W/day of melatonin; A2: group received 20 mg/kg B.W/day of melatonin for 30 days.

 

Table 3: Effect of different doses of melatonin on aspartate aminotransferase (AST), and Alanine transaminase (ALT) activity in rats.

Groups

Mean ± SE

AST (U/L)

ALT (U/L)

Control (A)

125.40 ±8.67 ab

41.40 ±4.37

A1

117.00 ±3.84 b

41.00 ±2.96

A2

145.00 ±6.99 a

39.00 ±1.52

LSD value

20.971 *

9.786 NS

P-value

0.0357

0.851

 

Means with different letters in the same column varied substantially. * (P≤0.05). Data are expressed as mean ± SE, N = 6 per group. A: control group rats were given D.W; A1: group got 10 mg/kg/B.W/day of melatonin; A2: group received 20 mg/kg B.W/day of melatonin for 30 days.

 

Histopathological study

The histopathological images (Figures 1 and 2) showed the normal histological structure of the liver in the control group. Meanwhile, the A1 group (Figures 3 and 4) displayed normal architecture, including intact sinusoids, hepatocytes, and central veins. In contrast, the liver sections from the A2 group (Figures 5 and 6) showed central vein congestion and sinusoidal dilation.

Discussions

Melatonin, a neurohormone primarily secreted by the pineal gland, is widely recognized for regulating circadian rhythms. However, recent studies have expanded its role to include the modulation of metabolic processes, body weight, and oxidative stress. In our study, we observed compelling evidence supporting the beneficial effects of melatonin, particularly at physiological or moderate doses. These findings align with earlier research, which demonstrated that exogenous melatonin can reduce body weight and fat accumulation, especially in animals exposed to high-fat, high-sugar diets (Ríos-Lugo et al., 2010; Tan et al., 2011). Long-term melatonin use was also associated with significant reductions in total cholesterol levels and weight gain, likely due to its ability to inhibit cholesterol synthesis, block absorption, and enhance catabolic pathways (Tung et al., 2020).

 

 

 

 

 

 

In addition to its role in metabolic regulation, melatonin exhibits potent antioxidant properties. It can directly scavenge free radicals and stimulate the activity of endogenous antioxidants, such as GSH, SOD, and glutathione peroxidase (GPx). Our findings confirm this protective effect, as animals treated with moderate doses of melatonin showed increased antioxidant enzyme activity, reduced levels of lipid peroxidation (LPO), and lower nitric oxide (NO) concentrations in liver and kidney tissues. These effects are consistent with previous reports suggesting that melatonin, even in small quantities, can neutralize up to two hydroxyl radicals and exert long-lasting antioxidant effects (Han et al., 2017; Colares et al., 2022). This makes melatonin a highly effective molecule for counteracting oxidative stress and maintaining cellular homeostasis. However, a key observation in our study is the dose-dependent nature of melatonin’s effects. While moderate doses promoted antioxidant defense and preserved tissue function, high doses were associated with potential toxicity, particularly in liver and kidney tissues. This was evident through biochemical and histological alterations, including elevated liver enzymes (AST, ALT), which serve as reliable indicators of hepatocellular injury (Kalas et al., 2021). These adverse outcomes suggest that melatonin, at supraphysiological levels, may act as a pro-oxidant rather than an antioxidant. Excessive ROS production, mitochondrial dysfunction, and disrupted redox balance are likely mechanisms underlying this toxicity, as proposed by Othman et al. (2020) and Al-Olayan et al. (2020).

The potential shift from a protective to a harmful role highlights the dual nature of melatonin, depending on its concentration. While low to moderate doses enhance mitochondrial efficiency and reduce oxidative load, high doses may overstimulate mitochondrial respiration, leading to electron leakage, increased ROS, and damage to cellular membranes through lipid peroxidation. Such changes impair membrane fluidity, permeability, and integrity eventually triggering apoptosis (Ighodaro et al., 2012). Furthermore, the liver’s central role in metabolism and detoxification makes it particularly vulnerable to oxidative damage, especially under prolonged exposure to high-dose melatonin.

Conclusion

The results of our study indicate that a daily dose of 10 mg of melatonin provides significant protection against both acute and chronic liver damage caused by various diseases. Additionally, it may serve as a useful therapeutic agent to minimize oxidative stress, which in turn helps reduce liver damage. However, the use of a high, long-term dose of 20 mg melatonin may pose risks to the animal, as it negatively affects body weight and disrupts the oxidant status.

Acknowledgements

For their collaboration on this study, the authors would like to thank the Department of Physiology, Biochemistry, and Pharmacology at the College of Veterinary Medicine, University of Baghdad, Iraq.

Novelty Statement

This article provides novel insights into the different doses of melatonin on liver function and oxidative stress in adult rats. Unlike previous studies that often focused on either low-dose or generalized antioxidant roles of melatonin, this research offers a direct comparison between two distinct doses (10mg/kg and 20mg/kg) and reveals that while the lower dose exerts protective antioxidant and hepatoprotective effects, the higher dose may lead to hepatic toxicity, offering new evidence on its potential risks at supraphysiological levels.

Author’s Contribution

Muna Hassan Yousef wrote the original draft of the study and carried out the experiments. Jawad Kadhim Arrak contributed to designing the study, the statistical evaluation, and the biological analysis. Sadiq Jaffer Ramadhan contributed to the manuscript’s histological examination and critical revision. The article’s final draft was reviewed and approved by all authors.

Ethical approval

The processes used in this study were reviewed and approved in compliance with animal welfare ethical standards by the Scientific Committee of the Department of Physiology, Biochemistry, and Pharmacology, College of Veterinary Medicine, University of Baghdad, Iraq, as well as the Ethics Committee of the College of Veterinary Medicine, University of Baghdad, Baghdad, Iraq.

Conflict of interest

The authors have declared no conflict of interest.

References

Abdullah RA, Ismail HK, Al-Hubaity AY (2022). Histological effect of gemcitabine on the liver and kidney of male rat with and without melatonin. Open Access Maced. J. Med. Sci., 10(A): 1242-1248. https://doi.org/10.3889/oamjms.2022.10071

Ahmad SB, Ali A, Bilal M, Rashid SM, Wani AB, Bhat RR, Rehman MU (2023). Melatonin and health: insights of melatonin action, biological functions, and associated disorders. Cell. Mol. Neurobiol., 43(6): 2437-2458. https://doi.org/10.1007/s10571-023-01324-w

Ahmed A, Awad M (2017). The effect of melatonin hormone on formaldehyde-induced liver injury in adult male albino rats: A light and electron microscopic study. Egypt. J. Anat., 40(2): 323-335. https://doi.org/10.21608/EJANA.2018.16909

Al-Olayan EM, Aloufi AS, AlAmri OD, Ola H, Moneim AEA (2020). Protocatechuic acid mitigates cadmium-induced neurotoxicity in rats: Role of oxidative stress, inflammation and apoptosis. Sci. Total Environ., 723: 137969. https://doi.org/10.1016/j.scitotenv.2020.137969

Bancroft JD, Gamble M (2008). Theory and practice of histological techniques. 6th Ed. Churchill Livingstone.

Boutin JA, Liberelle M, Yous S, Ferry G, Nepveu F (2024). Melatonin facts: Lack of evidence that melatonin is a radical scavenger in living systems. J. Pineal Res., 76(1): e12926. https://doi.org/10.1111/jpi.12926

Burtis C, Ashwood E (1999). Textbook of clinical chemistry. 3rd Ed. London. 2(33): 1145-1150.

Colares JR, Hartmann RM, Schemitt EG, Fonseca SR, Brasil MS, Picada JN, Marroni NP (2022). Melatonin prevents oxidative stress, inflammatory activity, and DNA damage in cirrhotic rats. World J. Gastroenterol., 28(3): 348. https://doi.org/10.3748/wjg.v28.i3.348

Delpino FM, Figueiredo LM (2021). Melatonin supplementation and anthropometric indicators of obesity: A systematic review and meta-analysis. Nutrition, 91: 111399. https://doi.org/10.1016/j.nut.2021.111399

Dun RL, Lan TY, Tsai J, Mao JM, Shao YQ, Hu XH, Peng Y (2022). Protective effect of melatonin for renal ischemia-reperfusion injury: A systematic review and meta-analysis. Front. Physiol., 12: 791036. https://doi.org/10.3389/fphys.2021.791036

Fernandez-Gil BI, Guerra-Librero A, Shen YQ, Florido J, Martínez-Ruiz L, García-López S, Escames G (2019). Melatonin enhances cisplatin and radiation cytotoxicity in head and neck squamous cell carcinoma by stimulating mitochondrial ROS generation, apoptosis, and autophagy. Oxid. Med. Cell. Long., 1: 7187128. https://doi.org/10.1155/2019/7187128

Guidet B, Shah SV (1989). Enhanced in vivo H2O2 generation by rat kidney in glycerol-induced renal failure. American Journal of Physiology-Renal Physiology. Am. J. Physiol., 257(26): 440. https://doi.org/10.1152/ajprenal.1989.257.3.F440

Haeger P, Bouchet A, Ossandon C, Bresky G (2019). Treatment with melatonin improves cognitive behavior and motor skills in a rat model of liver fibrosis. Ann. Hepatol., 18(1): 101-108. https://doi.org/10.5604/01.3001.0012.7867

Han QH, Huang B, Ding CB, Zhang ZW, Chen YE, Hu C, Yuan M (2017). Effects of melatonin on anti-oxidative systems and photosystem II in cold-stressed rice seedlings. Front. Plant Sci., 8: 785. https://doi.org/10.3389/fpls.2017.00785

Hernández-Velázquez B, Camara-Lemarroy CR, González-González JA, García-Compean D, Monreal-Robles R, Cordero-Pérez P, Muñoz-Espinosa LE (2016). Effects of melatonin on the acute inflammatory response associated with endoscopic retrograde cholangiopancreatography: A randomized, double-blind, placebo-controlled trial. Rev. Gastroenterol. México (English Edition), 81(3): 141-148. https://doi.org/10.1016/j.rgmxen.2016.06.014

Hyder I, Reddy PRK, Mukherjee J (2023). Physiology of digestion. In: Textbook of veterinary physiology. Singapore: Springer Nature Singapore. pp. 315-351. https://doi.org/10.1007/978-981-19-9410-4_13

Ighodaro OM, Omole JO, Ebuehi OA, Salawu FN (2012). Aluminium-induced liver and testicular damage: Effects of Piliostigma thonningii methanolic leaf extract. Nig. Q. J. Hosp. Med., 22(3): 158-163. https://doi.org/10.5402/2012/387942

Kalas MA, Chavez L, Leon M, Taweesedt PT, Surani S (2021). Abnormal liver enzymes: A review for clinicians. World J. Hepatol., 13(11): 1688–1698. https://doi.org/10.4254/wjh.v13.i11.1688

Kamoldinova RA (2023). Histophysiological peculiarities of the liver: Medical science. Ethiop. Int. J. Multidiscip. Res., 10(9): 8-13.

Kasim ZA, Ibrahim Z, Shukry M, Fahmy M, Mahmoud SS (2025). Melatonin mechanism to mitigate aging-related changes in the liver, kidney, and brain in rats. Egypt. J. Vet. Sci., 56(5): 993-1004.

Kennaway DJ (2017). Are the proposed benefits of melatonin-rich foods too hard to swallow. Crit. Rev. Food Sci. Nutr., 57(5): 958-962. https://doi.org/10.1080/10408398.2014.962686

Ko JW, Shin NR, Jung TY, Shin IS, Moon C, Kim SH, Kim JC (2019). Melatonin attenuates cisplatin-induced acute kidney injury in rats via induction of anti-aging protein, Klotho. Food Chem. Toxicol., 129: 201-210. https://doi.org/10.1016/j.fct.2019.04.049

Nogueira-Ferreira R, Oliveira PF, Ferreira R (2024). Liver metabolism: The pathways underlying glucose utilization and production. In: Glycolysis. Academic Press. pp. 141-156. https://doi.org/10.1016/B978-0-323-91704-9.00018-5

Oleshchuk O, Ivankiv Y, Falfushynska H, Mudra A, Lisnychuk N (2019). Hepatoprotective effect of melatonin in toxic liver injury in rats. Medicina, 55(6): 304. https://doi.org/10.3390/medicina55060304

Othman MS, Fareid MA, Abdel-Hameed RS, Abdel-Moneim AE (2020). The protective effects of melatonin on aluminum-induced hepatotoxicity and nephrotoxicity in rats. Oxid. Med. Cell. Long., 2020: 7375136. https://doi.org/10.1155/2020/7375136

Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zisapel N, Cardinali DP (2008). Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways. Progress Neurobiol., 85(3): 335-353. https://doi.org/10.1016/j.pneurobio.2008.04.001

Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre-Jimenez M, Qin L (2016). Melatonin as an antioxidant: Under promises but over delivers. J. Pineal Res., 61(3): 253-278. https://doi.org/10.1111/jpi.12360

Ren W, Liu G, Chen S, Yin J, Wang J, Tan B, Yin Y (2017). Melatonin signaling in T cells: Functions and applications. J. Pineal Res., 62(3): e12394. https://doi.org/10.1111/jpi.12394

Ríos-Lugo MJ, Cano P, Jiménez-Ortega V, Fernández-Mateos MP, Scacchi PA, Cardinali DP, Esquifino AI (2010). Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat–fed rats. J. Pineal Res., 49(4): 342-348. https://doi.org/10.1111/j.1600-079X.2010.00798.x

Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ (2007). One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species. J. Pineal Res., 42(1): 28-42. https://doi.org/10.1111/j.1600-079X.2006.00407.x

Tan DX, Manchester LC, Fuentes-Broto LPSD, Paredes SD, Reiter RJ (2011). Significance and application of melatonin in the regulation of brown adipose tissue metabolism: Relation to human obesity. Obesity Rev., 12(3): 167-188. https://doi.org/10.1111/j.1467-789X.2010.00756.x

Tung YT, Chiang PC, Chen YL, Chien YW (2020). Effects of melatonin on lipid metabolism and circulating irisin in sprague-dawley rats with diet-induced obesity. Molecules, 25(15): 3329. https://doi.org/10.3390/molecules25153329

Vašková J, Kočan L, Vaško L, Perjési P (2023). Glutathione-related enzymes and proteins: A review. Molecules (Basel, Switzerland), 28(3): 1447. https://doi.org/10.3390/molecules28031447